FDA Bashes Two Indian Drugmakers for Allegedly Flouting Procedures By Sam | April 11, 2016 The FDA has slammed two Indian drugmakers — Emcure Pharmaceuticals and Lupin —for purported GMP violations. Source: Drug GMP Report Posted in Drug GMP Report